Bio-Techne Corporation
72.25USD
-0.0600 (-0.08%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.43▼ | $0.44 | 1 | 0 |
| Next quarter | $0.48▼ | $0.49 | 1 | 0 |
| Current year | $2.02▼ | $2.06 | 2 | 0 |
| Next year | $2.31▼ | $2.31 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.52 | $0.52 | +0.00 (+0.1%) |
| 2026-03-31 | $0.53 | $0.53 | -0.00 (-0.8%) |
| 2025-12-31 | $0.43 | $0.46 | +0.03 (+5.8%) |
| 2025-09-30 | $0.42 | $0.42 | -0.00 (-0.4%) |
136 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $62 $73 | Aug 13, 2026 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $62 $73 | Jul 9, 2026 |
| TD Cowen | Downgraded from Buy | Hold | $65 $73 | Jun 30, 2026 |
| Benchmark | Downgraded from Buy | Hold | — | Jun 30, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $70 $73 | Jun 29, 2026 |
| Stephens & Co. | Downgraded from Overweight | Equal-Weight | $68 $73 | Jun 26, 2026 |
| William Blair | Downgraded from Outperform | Market Perform | — | Jun 26, 2026 |
| Baird | Maintained | Neutral | $49 $73 | Jun 26, 2026 |
| Piper Sandler | Initiated | Neutral | $65 | Jun 11, 2026 |
| Citigroup | Maintained | Buy | $80 $70 | May 7, 2026 |
| Wells Fargo | Maintained | Overweight | $76 $62 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $54 $50 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $68 $54 | Apr 6, 2026 |
| Wells Fargo | Maintained | Overweight | $70 $76 | Feb 6, 2026 |
| Citigroup | Maintained | Buy | $70 $80 | Feb 5, 2026 |
| Stifel | Maintained | Hold | $60 $65 | Feb 5, 2026 |
| TD Cowen | Maintained | Buy | $70 $80 | Feb 5, 2026 |
| UBS | Maintained | Buy | $70 $79 | Feb 5, 2026 |
| Evercore ISI Group | Maintained | In-Line | $62 $68 | Feb 5, 2026 |
| Evercore ISI Group | Downgraded from Outperform | In-Line | $68 $62 | Jan 5, 2026 |
| Argus Research | Maintained | Buy | $65 $68 | Nov 20, 2025 |
| UBS | Maintained | Buy | $65 $70 | Nov 6, 2025 |
| Wells Fargo | Maintained | Overweight | $59 $70 | Nov 6, 2025 |
| TD Cowen | Maintained | Buy | $65 $70 | Oct 14, 2025 |
| Evercore ISI Group | Maintained | Outperform | $60 $72 | Oct 7, 2025 |
70 filings from 15 insiders · 19 buy / 1 sell over 6m
Officers and directors of TECH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BOHNEN SHANEGeneral Counsel | Other | 4.3k | — | — | Aug 14, 2026 |
| HERR AMY E.Director | Otherindirect | 589 | — | — | Aug 14, 2026 |
| HIPPEL JAMESChief Financial Officer | Other | 9.8k | — | — | Aug 14, 2026 |
| KELDERMAN KIMChief Executive Officer | Other | 21.5k | — | — | Aug 14, 2026 |
| GEIST WILLIAMOfficer | Other | 6.4k | — | — | Aug 14, 2026 |
| CROUSE STEVEN C.Officer | Other | 5.4k | — | — | Aug 14, 2026 |
| HIPPEL JAMESChief Financial Officer | Exercise | 62.1k | $47.60 | $2.95M | Jul 29, 2026 |
| KELDERMAN KIMChief Executive Officer | Exercise | 35.0k | $47.60 | $1.67M | Jul 28, 2026 |
| BOHNEN SHANEGeneral Counsel | Exercise | 448 | $47.60 | $21k | Jul 23, 2026 |
| CROUSE STEVEN C.Officer | Other | 600 | — | — | Jun 2, 2026 |
| HERR AMY E.Director | Sellindirect | 6.6k | $48.28 | $320k | May 8, 2026 |
| HERR AMY E.Director | Exerciseindirect | 6.6k | $47.60 | $316k | May 8, 2026 |
| HIPPEL JAMESChief Financial Officer | Exercise | 62.0k | $47.60 | $2.95M | May 5, 2026 |
| KELDERMAN KIMChief Executive Officer | Exercise | 26.7k | $47.60 | $1.27M | May 5, 2026 |
| BOHNEN SHANEGeneral Counsel | Exercise | 8.4k | $47.60 | $400k | May 5, 2026 |
| CROUSE STEVEN C.Officer | Other | 794 | — | — | May 1, 2026 |
| HIPPEL JAMESChief Financial Officer | Other | 62.0k | — | — | Apr 22, 2026 |
| KELDERMAN KIMChief Executive Officer | Other | 11.3k | — | — | Apr 22, 2026 |
| KELDERMAN KIMChief Executive Officer | Exercise | 36.5k | $47.60 | $1.74M | Apr 14, 2026 |
| BOHNEN SHANEGeneral Counsel | Other | 2.3k | — | — | Apr 2, 2026 |
No analyst notes on TECH yet.
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 13 | 0 | 0 | Hold2.93 |
| 1 mo ago | 0 | 2 | 12 | 0 | 0 | Hold2.86 |
| 2 mo ago | 1 | 3 | 11 | 0 | 0 | Hold2.67 |